159 related articles for article (PubMed ID: 11134119)
21. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
[TBL] [Abstract][Full Text] [Related]
22. Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas.
Park HJ; Kim JY; Park KY; Gong G; Hong SJ; Ahn IM
Thyroid; 2000 Mar; 10(3):211-7. PubMed ID: 10779135
[TBL] [Abstract][Full Text] [Related]
23. Heterogeneity of TSH receptor-binding antibodies in Hashimoto's thyroiditis and Graves' disease.
De Bruin TW; Braverman LE; Brown RS
Am J Med Sci; 1990 May; 299(5):291-7. PubMed ID: 2337120
[TBL] [Abstract][Full Text] [Related]
24. Antithyroid peroxidase autoantibodies in thyroid diseases.
Mariotti S; Caturegli P; Piccolo P; Barbesino G; Pinchera A
J Clin Endocrinol Metab; 1990 Sep; 71(3):661-9. PubMed ID: 2168432
[TBL] [Abstract][Full Text] [Related]
25. The modulation of the human sodium iodide symporter activity by Graves' disease sera.
Ajjan RA; Findlay C; Metcalfe RA; Watson PF; Crisp M; Ludgate M; Weetman AP
J Clin Endocrinol Metab; 1998 Apr; 83(4):1217-21. PubMed ID: 9543144
[TBL] [Abstract][Full Text] [Related]
26. Patterns of cellular immune responses to thyrocyte membrane antigens and specific immunoregulatory defects in autoimmune thyroid disease.
O'Brien CJ; Macchia E; Cundy TF; Concetti R; McSorley CG; MacFarlane IG; Vento S; Eddleston AL
J Clin Lab Immunol; 1990 Jul; 32(3):103-8. PubMed ID: 1966945
[TBL] [Abstract][Full Text] [Related]
27. Anti-natrium/iodide symporter antibodies and other anti-thyroid antibodies in children with Turner's syndrome.
Kucharska AM; Czarnocka B; Demkow U
Adv Exp Med Biol; 2013; 756():131-8. PubMed ID: 22836628
[TBL] [Abstract][Full Text] [Related]
28. Relationship between thyroid autoimmunity and Yersinia enterocolitica antibodies.
Corapçioğlu D; Tonyukuk V; Kiyan M; Yilmaz AE; Emral R; Kamel N; Erdoğan G
Thyroid; 2002 Jul; 12(7):613-7. PubMed ID: 12193307
[TBL] [Abstract][Full Text] [Related]
29. Expression of the sodium iodide symporter in human kidney.
Spitzweg C; Dutton CM; Castro MR; Bergert ER; Goellner JR; Heufelder AE; Morris JC
Kidney Int; 2001 Mar; 59(3):1013-23. PubMed ID: 11231356
[TBL] [Abstract][Full Text] [Related]
30. Thyrotropin-receptor and thyroid peroxidase-specific T cell clones and their cytokine profile in autoimmune thyroid disease.
Fisfalen ME; Palmer EM; Van Seventer GA; Soltani K; Sawai Y; Kaplan E; Hidaka Y; Ober C; DeGroot LJ
J Clin Endocrinol Metab; 1997 Nov; 82(11):3655-63. PubMed ID: 9360522
[TBL] [Abstract][Full Text] [Related]
31. Monoclonal antibodies against the human sodium iodide symporter: utility for immunocytochemistry of thyroid cancer.
Castro MR; Bergert ER; Beito TG; Roche PC; Ziesmer SC; Jhiang SM; Goellner JR; Morris JC
J Endocrinol; 1999 Dec; 163(3):495-504. PubMed ID: 10588823
[TBL] [Abstract][Full Text] [Related]
32. Pendrin and NIS antibodies are absent in healthy individuals and are rare in autoimmune thyroid disease: evidence from a Danish twin study.
Brix TH; Hegedüs L; Weetman AP; Kemp HE
Clin Endocrinol (Oxf); 2014 Sep; 81(3):440-4. PubMed ID: 24612086
[TBL] [Abstract][Full Text] [Related]
33. Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2).
Phenekos C; Vryonidou A; Gritzapis AD; Baxevanis CN; Goula M; Papamichail M
Neuroimmunomodulation; 2004; 11(4):209-13. PubMed ID: 15249726
[TBL] [Abstract][Full Text] [Related]
34. Studies of thyroid xenografts from Graves' disease in severe combined immunodeficient mice.
Morita T; Yoshikawa N; Akasu F; Resetkova E; Arreaza G; Miller N; Jamieson C; Volpé R
J Clin Endocrinol Metab; 1993 Jul; 77(1):255-61. PubMed ID: 8100830
[TBL] [Abstract][Full Text] [Related]
35. The immune response to the iodide transporter.
Spitzweg C; Morris JC
Endocrinol Metab Clin North Am; 2000 Jun; 29(2):389-98, viii. PubMed ID: 10874536
[TBL] [Abstract][Full Text] [Related]
36. Increased differentiation of Th22 cells in Hashimoto's thyroiditis.
Bai X; Sun J; Wang W; Shan Z; Zheng H; Li Y; Zhao Y; Gong M; Teng W
Endocr J; 2014; 61(12):1181-90. PubMed ID: 25242258
[TBL] [Abstract][Full Text] [Related]
37. Autoantibody against thyroid iodide transporter in the sera from patients with Hashimoto's thyroiditis possesses iodide transport inhibitory activity.
Endo T; Kaneshige M; Nakazato M; Kogai T; Saito T; Onaya T
Biochem Biophys Res Commun; 1996 Nov; 228(1):199-202. PubMed ID: 8912659
[TBL] [Abstract][Full Text] [Related]
38. Application of a bioassay with CHO cells for the routine detection of stimulating and blocking autoantibodies to the TSH-receptor.
Morgenthaler NG; Pampel I; Aust G; Seissler J; Scherbaum WA
Horm Metab Res; 1998 Mar; 30(3):162-8. PubMed ID: 9566861
[TBL] [Abstract][Full Text] [Related]
39. Implications of the molecular characterization of the sodium-iodide symporter (NIS).
Schmutzler C; Köhrle J
Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 3():S1-10. PubMed ID: 9865544
[TBL] [Abstract][Full Text] [Related]
40. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay.
Morgenthaler NG; Hodak K; Seissler J; Steinbrenner H; Pampel I; Gupta M; McGregor AM; Scherbaum WA; Banga JP
Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
